Announcement:
Novartis and Generate:Biomedicines Announce Collaboration
Now we can:
Celebrated on the 2024 CNBC Disruptor 50 List
Contact
Curious about our work? Get in touch.
InvestorsJason Silversinvestors@generatebiomedicines.com
Media InquiriesMegan McLaughlinpr@generatebiomedicines.com
Collaboration & PartnershipsSahm Nasseripartner@generatebiomedicines.com